Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-038555
Filing Date
2017-06-08
Accepted
2017-06-08 16:33:16
Documents
2
Period of Report
2017-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7802
2 POA DOCUMENT poa.txt EX-24.4_729930 3299
  Complete submission text file 0001209191-17-038555.txt   12420
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address BONTE KRAAILAAN 1 ALMERE P7 1343AJ
Business Address
Petry Harald (Reporting) CIK: 0001693830 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 17900567